14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
EXP vs CRH: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Eagle Materials, Inc. (EXP) is the stronger overall head-to-head candidate over CRH Public Limited Company (CRH) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EXP carries a Unified Composite Score of 38.7/100 (SELL) at $172.25 (13.6x Forward P/E, 21.8% operating margin), whereas CRH carries 46.0/100 (HOLD) at $88.05 (14.7x Forward P/E, 14.1% operating margin).
Composite vs. Pillar Nuance: While CRH currently prints a higher short-term Unified Composite Score (46.0/100 HOLD vs. EXP 38.7/100 SELL), EXP captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (21.8% vs. 14.1% operating margin) and revenue trajectory (+2.2% vs. +3.0% YoY).
Technical & Structure Timing Caution: EXP is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.0); meanwhile CRH is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EXP vs CRH. Trailing 12-month operating profitability (EXP 21.8% vs CRH 14.1%) and valuation multiples (EXP 13.6x vs CRH 14.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Building Materials value chain with $60.2B market capitalization and 14.1% operating margin.
OpEx & R&D Reinvestment22.1% of Rev ($8.61B)
90D Engineering Disclosures0 Published
Investor FAQ EXP vs CRH Key Questions & Quantitative Answers
As of Nov 20, 2026, Eagle Materials, Inc. (EXP) is the stronger overall head-to-head candidate over CRH Public Limited Company (CRH) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EXP carries a Unified Composite Score of 38.7/100 (SELL) at $172.25 (13.6x Forward P/E, 21.8% operating margin), whereas CRH carries 46.0/100 (HOLD) at $88.05 (14.7x Forward P/E, 14.1% operating margin). Composite vs. Pillar Nuance: While CRH currently prints a higher short-term Unified Composite Score (46.0/100 HOLD vs. EXP 38.7/100 SELL), EXP captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–2 across the 6 pillars) due to superior fundamental profitability (21.8% vs. 14.1% operating margin) and revenue trajectory (+2.2% vs. +3.0% YoY). Technical & Structure Timing Caution: EXP is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 41.0); meanwhile CRH is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CRH leads the Growth & Scale pillar: EXP posts +2.2% YoY revenue growth and -14.2% YoY earnings growth on $2.34B TTM revenue (25.8% gross margin, 21.8% operating margin), compared with CRH at +3.0% YoY revenue growth and -15.8% YoY earnings growth on $39.0B TTM revenue (36.2% gross margin, 14.1% operating margin). On trailing 12-month operating scale, EXP generates $2.34B in USD-normalized revenue versus $39.0B for CRH. In operating R&D and SG&A reinvestment, EXP deploys 4.0% of Rev ($94M) (0 90-day corporate R&D disclosures) versus 22.1% of Rev ($8.61B) (0 disclosures) for CRH.
EXP screens cheaper on headline valuation multiples. EXP trades at 13.6x Forward P/E, 14.4x Trailing P/E, 2.09x PEG, and 2.3x EV/Revenue (28.8% EBITDA margin), whereas CRH trades at 14.7x Forward P/E, 17.1x Trailing P/E, 1.63x PEG, and 1.5x EV/Revenue (19.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EXP (24.5% ROE) versus CRH (13.9% ROE) capital efficiency.
In options market volatility and institutional positioning, EXP carries 28.8% implied volatility (16th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.91β · 40% Vol realized risk). By comparison, CRH carries 19.2% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.04β · 43% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.